Kuslima Shogen

2.0k total citations
47 papers, 1.7k citations indexed

About

Kuslima Shogen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kuslima Shogen has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Kuslima Shogen's work include Cancer, Hypoxia, and Metabolism (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Cancer-related Molecular Pathways (6 papers). Kuslima Shogen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Cancer-related Molecular Pathways (6 papers). Kuslima Shogen collaborates with scholars based in United States, Germany and Poland. Kuslima Shogen's co-authors include Wojciech Ardelt, Stanislaw M. Mikulski, Zbigniew Darżynkiewicz, Shailendra K. Saxena, Barbara Ardelt, Richard J. Youle, Alberto Viera, Intae Lee, H Menduke and Maneth Gravell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kuslima Shogen

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuslima Shogen United States 23 1.2k 295 201 200 186 47 1.7k
Stanislaw M. Mikulski United States 21 1.2k 1.0× 374 1.3× 195 1.0× 209 1.0× 172 0.9× 41 1.8k
Susanna M. Rybak United States 27 1.1k 0.9× 559 1.9× 142 0.7× 189 0.9× 48 0.3× 54 1.8k
U.A. Ramagopal United States 27 1.1k 0.9× 1.0k 3.4× 287 1.4× 62 0.3× 195 1.0× 53 2.6k
Dohn G. Glitz United States 24 1.3k 1.1× 198 0.7× 229 1.1× 34 0.2× 92 0.5× 58 1.7k
Jarrett Adams Canada 24 1.1k 0.9× 548 1.9× 104 0.5× 183 0.9× 63 0.3× 53 1.9k
Michael W. Spellman United States 24 1.9k 1.5× 617 2.1× 119 0.6× 167 0.8× 48 0.3× 27 2.8k
Paola Fortugno Italy 18 1.1k 0.9× 443 1.5× 100 0.5× 45 0.2× 33 0.2× 42 1.8k
Stanley M. Tahara United States 30 2.5k 2.0× 196 0.7× 263 1.3× 63 0.3× 118 0.6× 63 3.3k
Ronald Ellis United States 20 1.6k 1.3× 339 1.1× 849 4.2× 111 0.6× 39 0.2× 46 2.6k
Eleanor K. Spicer United States 24 2.1k 1.8× 194 0.7× 544 2.7× 34 0.2× 124 0.7× 45 2.7k

Countries citing papers authored by Kuslima Shogen

Since Specialization
Citations

This map shows the geographic impact of Kuslima Shogen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuslima Shogen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuslima Shogen more than expected).

Fields of papers citing papers by Kuslima Shogen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuslima Shogen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuslima Shogen. The network helps show where Kuslima Shogen may publish in the future.

Co-authorship network of co-authors of Kuslima Shogen

This figure shows the co-authorship network connecting the top 25 collaborators of Kuslima Shogen. A scholar is included among the top collaborators of Kuslima Shogen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuslima Shogen. Kuslima Shogen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holloway, Daniel E., Umesh Singh, Kuslima Shogen, & K. Ravi Acharya. (2011). Crystal structure of Onconase at 1.1 Å resolution – insights into substrate binding and collective motion. FEBS Journal. 278(21). 4136–4149. 14 indexed citations
2.
Halicka, H. Dorota, et al.. (2008). Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines. Cancer Biology & Therapy. 7(7). 1104–1108. 33 indexed citations
3.
Zhao, Hong, Barbara Ardelt, Wojciech Ardelt, Kuslima Shogen, & Zbigniew Darżynkiewicz. (2008). The cytotoxic ribonuclease onconase targets RNA interference (siRNA). Cell Cycle. 7(20). 3258–3261. 36 indexed citations
4.
Ardelt, Wojciech, Kuslima Shogen, & Zbigniew Darżynkiewicz. (2008). Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes. Current Pharmaceutical Biotechnology. 9(3). 215–225. 84 indexed citations
5.
Kim, Eun Ju, Anna Kalota, Alan M. Gewirtz, et al.. (2007). Possible Mechanisms Of Improved Radiation Response By Cytotoxic Rnase, Onconase®, On A549 Human Lung Cancer Xenografts Of Nude Mice. Advances in experimental medicine and biology. 599. 53–59. 14 indexed citations
6.
Schulenburg, Cindy, Barbara Ardelt, Wojciech Ardelt, et al.. (2007). The interdependence between catalytic activity, Conformational stability and cytotoxicity of onconase. Cancer Biology & Therapy. 6(8). 1244–1250. 20 indexed citations
7.
Ardelt, Barbara, Wojciech Ardelt, Piotr Pożarowski, et al.. (2007). Cytostatic and Cytotoxic Properties of Amphinase: A Novel Cytotoxic Ribonuclease fromRana pipiensOocytes. Cell Cycle. 6(24). 3097–3102. 17 indexed citations
8.
Lee, Intae, et al.. (2007). The therapeutic mechanisms of ranpirnase-induced enhancement of radiation response on A549 human lung cancer.. PubMed. 21(5). 721–8. 12 indexed citations
9.
Michaelis, Martin, Jaroslav Činátl, Florian Rothweiler, et al.. (2006). Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Letters. 250(1). 107–116. 41 indexed citations
10.
Lee, Intae, Young Ho Lee, Stanislaw M. Mikulski, & Kuslima Shogen. (2003). Effect of Onconase ± Tamoxifen on ASPC-1 Human Pancreatic Tumors in Nude Mice. Advances in experimental medicine and biology. 530. 187–196. 23 indexed citations
11.
Halicka, Dorota, Piotr Pożarowski, Wojciech Ardelt, et al.. (2002). Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase). International Journal of Oncology. 21(6). 1245–50. 22 indexed citations
12.
Saxena, Shailendra K., Ravi Sirdeshmukh, Wojciech Ardelt, et al.. (2002). Entry into Cells and Selective Degradation of tRNAs by a Cytotoxic Member of the RNase A Family. Journal of Biological Chemistry. 277(17). 15142–15146. 89 indexed citations
13.
Halicka, H. Dorota, T. Murakami, Abraham Mittelman, et al.. (2000). Induction of differentiation of leukaemic (HL‐60) or prostate cancer (LNCaP, JCA‐1) cells potentiates apoptosis triggered by onconase. Cell Proliferation. 33(6). 407–417. 19 indexed citations
14.
Lee, Young Ho, et al.. (2000). Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase.. PubMed. 20(2A). 1037–40. 13 indexed citations
15.
Lee, Intae, et al.. (2000). Tumoricidal effects of Onconase on various tumors. Journal of Surgical Oncology. 73(3). 164–171. 32 indexed citations
16.
17.
18.
Mosimann, S.C., Kathy Johns, Wojciech Ardelt, et al.. (1992). Comparative molecular modeling and crystallization of P‐30 protein: A novel antitumor protein of Rana pipiens oocytes and early embryos. Proteins Structure Function and Bioinformatics. 14(3). 392–400. 14 indexed citations
19.
Mikulski, Stanislaw M., Alberto Viera, Wojciech Ardelt, H Menduke, & Kuslima Shogen. (1990). Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P‐30 protein, a novel protein possessing anti‐tumour activity. Cell Proliferation. 23(3). 237–246. 38 indexed citations
20.
Darżynkiewicz, Zbigniew, et al.. (1988). Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer Agent. Cell Proliferation. 21(3). 169–182. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislaw M. Mikulski Breakdown of academic impact, for papers by Susanna M. Rybak Breakdown of academic impact, for papers by U.A. Ramagopal Breakdown of academic impact, for papers by Dohn G. Glitz Breakdown of academic impact, for papers by Jarrett Adams Breakdown of academic impact, for papers by Michael W. Spellman Breakdown of academic impact, for papers by Paola Fortugno Breakdown of academic impact, for papers by Stanley M. Tahara Breakdown of academic impact, for papers by Ronald Ellis Breakdown of academic impact, for papers by Eleanor K. Spicer
Rankless by CCL
2026